Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOP-CDH: Sildenafil in Neonatal CDH
NCT05201144Phase 2Recruiting
- Sponsor
- University of Utah
- Start
- Sep 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in pulmonary hypertension (PH), sponsored by University of Utah. Started Sep 2022; status: recruiting.
02
Drugs
ASP-001
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT05201144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05201144.